Gyre Therapeutics GYRE
NASDAQ GYRE
$7.00 -0.33 (-4.50%)
At close: Oct 1, 2026 · 4:00 PM EDT

Gyre Therapeutics (GYRE) EV to CFO (2014 - 2026)

Updated

Gyre Therapeutics' (GYRE) EV to CFO stood at 143.46 in Q1 2026, down 74.9% from the prior quarter.

Analysis

Gyre Therapeutics (GYRE) EV to CFO (2014 - 2026) Analysis & Trends

On a TTM basis, Gyre Therapeutics' EV to CFO came in at 102.20 as of Mar 31, 2026; for FY2025, it came in at 571.42.

  • Across earlier years, EV to CFO came in at 75.85 in FY2023 and 2.62 in FY2022.
  • The Q1 2026 figure is the lowest quarterly EV to CFO since Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Gyre Therapeutics 777.23 Mn 579.94 Mn 26.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 143.46
Dec 31, 2025 571.42
Sep 30, 2025 168.56
Sep 30, 2024 438.32
Jun 30, 2024 123.41
Mar 31, 2024 81.05
Dec 31, 2023 75.85
Sep 30, 2023 0.25
Jun 30, 2023 0.13
Mar 31, 2023 -0.01
Dec 31, 2022 2.62
Jun 30, 2015 5.43
Mar 31, 2015 12.21
Sep 30, 2014 1.58
API Access

Gyre Therapeutics EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=GYRE&period=max&api_key=YOUR_API_KEY